rs1554094927
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_000337.6(SGCD):c.4-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,551,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000337.6 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCD | NM_000337.6 | c.4-1G>A | splice_acceptor_variant, intron_variant | ENST00000337851.9 | NP_000328.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCD | ENST00000337851.9 | c.4-1G>A | splice_acceptor_variant, intron_variant | 1 | NM_000337.6 | ENSP00000338343.4 | ||||
SGCD | ENST00000435422.7 | c.1-1G>A | splice_acceptor_variant, intron_variant | 1 | ENSP00000403003.2 | |||||
SGCD | ENST00000517913.5 | c.4-1G>A | splice_acceptor_variant, intron_variant | 5 | ENSP00000429378.1 | |||||
SGCD | ENST00000524347.2 | n.4-1G>A | splice_acceptor_variant, intron_variant | 5 | ENSP00000430794.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151694Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000243 AC: 34AN: 1399654Hom.: 0 Cov.: 30 AF XY: 0.0000230 AC XY: 16AN XY: 694392
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151694Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74062
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2F Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change affects an acceptor splice site in intron 2 of the SGCD gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SGCD are known to be pathogenic (PMID: 8841194, 10735275, 10838250). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SGCD-related conditions. ClinVar contains an entry for this variant (Variation ID: 532691). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 12, 2019 | - - |
Dilated cardiomyopathy 1L Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Nov 21, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at